Long-Term Metformin Use May Lower Risk of Dry AMD


Metformin, a common diabetes drug, might help protect against age-related macular degeneration (AMD), especially the dry form. In a study of over 3,700 older diabetic patients, those who took metformin for at least five years had a lower AMD rate (3.3%) than those who didn’t (4.9%). The risk reduction was stronger for people taking it for six or more years.

The benefit was clear for dry AMD but not significant fo
r wet AMD. Researchers think metformin’s antioxidant and anti-inflammatory properties may help prevent AMD from developing, though it doesn’t seem to slow disease once advanced.

Importantly, the study found that insulin didn’t affect AMD risk, while statins showed a protective effect, supporting the findings about metformin. Still, the authors caution that more research—especially long-term clinical trials—is needed to confirm whether taking metformin for many years truly lowers AMD risk.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH